Navigation Links
Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)
Date:2/29/2008

ROCKVILLE, Md., Feb. 29 /PRNewswire-FirstCall/ -- A study reported in the journal Pharmacogenomics suggests that a genetic variation in the Ciliary Neurotrophic Factor gene (CNTF) may affect response to antipsychotic treatment. The study, conducted by Vanda Pharmaceuticals Inc., included patients with acute symptoms of schizophrenia who were treated either with Fiapta(TM) (iloperidone), a novel atypical antipsychotic agent currently under review with the FDA, or placebo. Patients were also studied for a genetic variation in the CNTF gene. CNTF is a neurotrophic factor important for neuronal survival and recovery after injury. About 75% of the population carry two intact copies of the CNTF protein while 25% carry one or two truncated copies of the protein.

As previously reported in the clinical study overall, it was shown that Fiapta(TM) was significantly more effective than placebo in treating both the positive and negative symptoms of schizophrenia. In addition, Fiapta(TM) showed significant improvement from baseline in all symptoms across all patient genotypes of CNTF.

In the patient population carrying both intact copies of CNTF (representing 75% of the population), Fiapta(TM) treatment was significantly better than placebo in symptom improvement. In patients carrying at least one truncated copy of the CNTF protein, placebo and Fiapta(TM) treated patients had a significant improvement from baseline indicating an enhanced placebo response among this group of patients.

"This is a pioneering effort in understanding why some people respond to antipsychotic medication and others do not. The results of this prospective study on the genetics of drug response offer tantalizing clues on the involvement of neurotrophic factors in schizophrenia," said Steven G. Potkin, MD, Professor of Psychiatry, Robert R. Sprague Chair in Brain Imaging, and Director, Clinical Psychiatric Research at the University of California, Irvine.

These findings su
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections
2. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
3. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
4. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
5. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
6. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
7. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
8. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
9. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
10. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
11. Genetics Determine Optimal Drug Dose of Common Anticoagulant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... on Thursday, August 7, 2014 before markets open. The ... conference call at 8:00 a.m. Eastern time (5:00 a.m. ... call and webcast to discuss financial results and recent ... calling (800) 708-4540 (domestic) or (847) 619-6397 (international), participant ...
(Date:7/31/2014)... Cipla Europe NV ("Cipla") ... entered into a commercial collaboration, covering the territory ... countries, for BioQuiddity,s OneDose ReadyfusOR™ in regional anesthetic ... launch the CE Marked OneDose ReadyfusOR pre-filled with ... market late this year. The ready-to-use infusion systems ...
(Date:7/31/2014)... and NOTTINGHAM, England , July ... CBRX ) today announced that its ... announced a collaboration that will support pharmaceutical and ... development stage.  Molecular Profiles, pharmaceutical development services will ... metabolism and pharmacokinetics (DMPK) to give clients a ...
Breaking Medicine Technology:Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management 2Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management 3Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3
(Date:7/31/2014)... RankingBySEO, a prominent internet marketing company, has ... against whom negative reviews are there. The company has ... , About the service, a senior management executive of ... now, but we have been helping individuals and business ... years.” , On being asked about the service cost, ...
(Date:7/31/2014)... MD (PRWEB) July 31, 2014 FITNESS ... San Francisco, announced that they will upgrade all locations ... MoSo, MyClub, and MoSo Pay. Motionsoft is a leading ... solutions that automate member management and payments services for ... member relationship management suite, which FITNESS SF bundled with ...
(Date:7/31/2014)... California (PRWEB) July 31, 2014 ... expected to reach USD 37.83 billion by 2020, ... Research, Inc. Increasing geriatric population base augmenting the ... cardiovascular, orthopedic, and respiratory diseases coupled with increasing ... growth over the next six years. Some of ...
(Date:7/31/2014)... HealthDay Reporter WEDNESDAY, July ... is growing increasingly resistant to the drugs commonly used to ... drugs are in development, and at least one in early ... "Although there has been considerable progress in malaria control ... from won, and there is still much more to do," ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Recently, Agebc.com, a ... dresses, has revealed its new selection of trendy mother ... them are offered at promotional prices now, up to 68% ... line by adding the new range of mother of the ... to the international clients. So far, our online shop has ...
Breaking Medicine News(10 mins):Health News:RankingBySEO Launches a New Service ‘Remove Negative Comments’ 2Health News:FITNESS SF Upgrades Motionsoft Software to Include Entire Product Lineup: MoSo + MoSo Pay + MyClub 2Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 2Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 4Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 5Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 6Health News:Malaria Growing Resistant to Drugs Used to Fight It 2Health News:Malaria Growing Resistant to Drugs Used to Fight It 3Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2
... With the fall and winter influenza season already underway, ... even greater impact than the spring outbreak of H1N1 ... SunGard Availability Services today outlined the business, operational and ... developing pandemic plans to improve preparedness for potential ...
... , ROCKVILLE, Md., Oct. 26 Lockheed Martin (NYSE: ... new Health & Human Services (HHS) information technology contracts, ... systems. , The new contracts include $142 million for ... contract, and $28 million for the National Institutes of ...
... particle or ion therapy radiation with heavy ions and ... in Heidelberg. Well over 600 international participants, especially from Japan ... the annual meeting of the "Particle Therapy Cooperative Group" (PTCOG), ... physics and oncology. "There have been significant advances ...
... 2009The world,s fastest supercomputer, Roadrunner, at Los Alamos ... doing accelerated petascale computer modeling and simulations of ... The Roadrunner system is now beginning its transition ... and reliability of the U.S. nuclear deterrent. ...
... are unclear, researchers say , MONDAY, Oct. 26 (HealthDay ... follow-up after discovery of a breast abnormality, a U.S. ... can mean breast cancer is detected at a later ... researchers noted. , Researchers at the University of South ...
... 1, 1999 Chicago Bears fans and the organ donation community ... legend and organ donation advocate, Walter Payton. Payton, who ... passed away at the age of 45 while on the ... honor of Payton, Donate Life Illinois (DLI) and Astellas Pharma ...
Cached Medicine News:Health News:SunGard Availability Services Addresses the Business, Operational and Workforce Issues Involved in Pandemic Planning 2Health News:SunGard Availability Services Addresses the Business, Operational and Workforce Issues Involved in Pandemic Planning 3Health News:SunGard Availability Services Addresses the Business, Operational and Workforce Issues Involved in Pandemic Planning 4Health News:Lockheed Martin Expands Health IT Business with $170 Million in New Health & Human Services Contract Awards 2Health News:The largest congress worldwide on ion therapy in Heidelberg 2Health News:Science at the petascale: Roadrunner results unveiled 2Health News:Science at the petascale: Roadrunner results unveiled 3Health News:Breast Abnormality Follow-Up Often Later in Black Women 2Health News:Donate Life Illinois, Astellas and the Chicago Bears Partner to Tackle the Shortage in Honor of Bears Legend, Walter Payton 2Health News:Donate Life Illinois, Astellas and the Chicago Bears Partner to Tackle the Shortage in Honor of Bears Legend, Walter Payton 3Health News:Donate Life Illinois, Astellas and the Chicago Bears Partner to Tackle the Shortage in Honor of Bears Legend, Walter Payton 4
... The VitalView™ Central Station is a ... bedside monitors for vital signs monitoring. ... in real time, with simultaneous display ... events, graphical and tabular trends are ...
... The Gemini Family of infusion ... with a collective series of ... product line offers a wide ... IV sets, each featuring the ...
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
... Infusion System many of its innovations ... as the principles of human factors ... to the creation of a medical ... to reduce errors in operation while ...
Medicine Products: